Cigna earnings beat by $0.04, revenue topped estimates
LONDON - Riverstone (LON:RSER) Energy Limited (REL) has announced that its Non-Executive Director, John Roche, has joined the board of Syncona Limited as a non-executive director. The appointment, which took effect on October 1, 2024, was disclosed by Roche in compliance with UK Listing Rule 6.4.9 (2) R.
Syncona Limited is recognized as a prominent investor in the life science sector, with a portfolio that includes global leaders in the field. The company’s strategic focus is on the creation, development, and expansion of its life science investments.
REL, a closed-ended investment company, has its ordinary shares listed on the London Stock Exchange (LON:LSEG) under the ticker symbol RSE. The company’s investment strategy spans various segments of the energy industry, including decarbonization, oil and gas, renewable energy, and power. REL’s investments are geographically diverse, with assets in the Continental U.S., Western Canada, Europe, and Australia.
In related news, REL informed shareholders that one of its investments, Crescent Point Energy Corp (TSX:VRN)., underwent a rebranding to Veren Inc. on May 10, 2024. Veren Inc. now trades on both the Toronto Stock Exchange and the New York Stock Exchange with the ticker symbol "VRN."
The information regarding John Roche’s new directorship and REL’s investment updates is based on a press release statement. The company has not incorporated any content from its website or any linked websites into this announcement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.